BackInitiator Pharma A/S Overview

Initiator Pharma A/S Receivables

Initiator Pharma A/S's receivables is $3.8M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$3.82M

Peer trimmed avg / median

Loading

Initiator Pharma A/S Receivables History

Loading

Initiator Pharma A/S vs. peers: Receivables Comparison

Loading

Initiator Pharma A/S Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Initiator Pharma A/S (INIT.ST) FAQ

Initiator Pharma A/S (INIT.ST) currently reports a receivables of $3.8M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Initiator Pharma A/S's receivables history and peer comparisons.

Initiator Pharma A/S's receivables changed from $0 to $3.8M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Initiator Pharma A/S reported $3.8M in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $3.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Initiator Pharma A/S, and consider following INIT.ST for alerts when major investors trade the stock.

Initiator Pharma A/S is classified in the Healthcare sector. On receivables, it currently shows $3.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INIT.ST with unrelated industries.